RPRX
NASDAQStockRoyalty Pharma plc
$46.12-0.57 (-1.22%)
52-Week Range
$30.85
$47.48
Key Stats
Market Cap
19.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.42
Volume
2.4M
Avg Volume
3.3M
Performance
1M
+3.66%
3M
+19.05%
6M
+30.50%
YTD
+18.04%
1Y
+40.36%
3Y
+38.12%
5Y
-2.07%
Price Chart
ETF Exposure
RPRX is held by 188 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| JKD | iShares Morningstar U.S. Equity ETF | 0.03% |
| SCHB | Schwab U.S. Broad Market ETF | 0.03% |
| VONE | Vanguard Russell 1000 ETF | 0.03% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.03% |
| KOKU | Xtrackers MSCI Kokusai Equity ETF | 0.03% |
| SCHZ | Schwab U.S. Aggregate Bond ETF | 0.03% |
| TOK | iShares MSCI Kokusai ETF | 0.02% |
| VTHR | Vanguard Russell 3000 ETF | 0.02% |
| PRF | Invesco RAFI US 1000 ETF | 0.02% |
| URTH | iShares MSCI World ETF | 0.02% |
| BALI | iShares U.S. Large Cap Premium Income Active ETF | 0.02% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.02% |
| ACWI | iShares MSCI ACWI ETF | 0.02% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.02% |
| FNDB | Schwab Fundamental U.S. Broad Market Index ETF | 0.02% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.02% |
| SFY | SoFi Select 500 ETF | 0.02% |
| SPUT | Innovator Equity Premium Income – Daily PutWrite ETF | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| QUS | State Street SPDR MSCI USA StrategicFactors ETF | 0.01% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.01% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.01% |
| QWLD | State Street SPDR MSCI World StrategicFactors ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.01% |
| CPI | IQ Real Return ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| IALT | iShares Systematic Alternatives Active ETF | 0.00% |
| INRO | iShares U.S. Industry Rotation Active ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.00% |
PreviousPage 4 of 4
About RPRX ETF Exposure
Royalty Pharma plc (RPRX) is held by 188 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 19.8B, RPRX is a widely held institutional stock. The stock currently trades at $46.12. Investors can gain exposure to RPRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RPRX, sorted by portfolio weight.